Sven M. Deutschmann, PhD Roche Diagnostics GmbH

Sven Deutschmann studied biology at the University of Brunswick where he obtained his PhD in cell culture technology. In 1995 he joined Roche. His current position is Head of Analytical Science and Technology “Adventitious Agents Testing & Alternative Microbiological Methods” within Global Quality and Compliance. In this role he is responsible for the Adventitious Agents Control Concept and the evaluation, validation and implementation of alternative microbiological methods.

Besides his global responsibilities within Roche he is member of the German Pharmacopeia Commission and its Microbiology Committee, as well as Germany’s representative in the Working Party “Bacterial Endotoxins”, and Chairman of the Working Party “Mycoplasmas” and the Expert Group 1 “Biological Methods and Statistical Analysis” of the European Pharmacopeia Commissions in Strasbourg, France. In 2009 he was appointed as commissioner of the Central Commission for Biological Safety, a brains trust of the Federal Office of Consumer Protection and Food Safety. In addition, he is member of PDA Task Forces resp. co-author of PDA-Technical Reports (TR #50, TR #69, and the draft version of TR “Post Approval Change Management for Biologics and Pharmaceutical Drug Products"), chairman of the Advisory Board of the ECA “Pharmaceutical Microbiology” Interest Group and member of various BioPhorum work-streams.